A non-covalent peptide-based strategy for siRNA delivery.
about
Cell penetrating peptides in the delivery of biopharmaceuticals.A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathwayHuman-protein-derived peptides for intracellular delivery of biomolecules.Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.Harnessing RNAi nanomedicine for precision therapyPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.An integrated miRNA functional screening and target validation method for organ morphogenesis.Polycation-based nanoparticle delivery for improved RNA interference therapeutics.Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growthTracking in vitro and in vivo siRNA electrotransfer in tumor cells.Special delivery: targeted therapy with small RNAs.Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics.Using non-coding small RNAs to develop therapies for Huntington's disease.Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.Enhancing endosomal escape for nanoparticle mediated siRNA delivery.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Peptides used in the delivery of small noncoding RNA.Sequence-defined shuttles for targeted nucleic acid and protein delivery.Peptide-mediated delivery: an overview of pathways for efficient internalization.Functional peptides for siRNA delivery.Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs.B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.Skin cell targeting with self-assembled ligand addressed nanoemulsion droplets.Cellular Antisense Activity of PNA-Oligo(bicycloguanidinium) Conjugates Forming Self-Assembled Nanoaggregates.
P2860
Q33649501-76B40381-577C-4207-99ED-A382209FEEA7Q33712960-60D8EC53-D39A-4EF3-9CF2-9C77FF2C3C2FQ34009331-0363922C-197E-40F3-B0D1-203DEE67B69FQ34093882-D4F506E2-9762-4591-A726-64BF98F06FD1Q34152538-31AEB0AD-8513-4862-89C1-5FAF7EFBAD00Q35673875-C92379D0-C5F4-41F6-984B-2DF7D2CA1B4FQ35783096-F5776B20-2017-4829-9189-294F8F70C9FFQ36388879-3DC7D24B-C5F9-4DC0-907A-6C658191759EQ36512557-5B37DD2B-3DFA-47D7-B046-0D094E11DECDQ36691077-8D31B418-F305-468D-A445-822A0AA8A5A0Q37012046-24619F3C-1448-4676-B57D-E6DE3E22034AQ37043911-7DCBE636-BB4A-413A-813F-80E38BDE38A2Q37230918-AB1FF19B-1C98-4272-9CBA-08D2EDFBA002Q37298570-C3A91077-98BD-41AA-956A-4ECB8ABD115EQ37331691-06FE3333-8C16-487C-B24C-CF0A435E3998Q37864924-DC217C0C-B9B2-4835-8CF7-88A89E310A89Q37921774-0D405BD6-6465-46AB-BBE4-E0E31884A26EQ37967034-2EDEF8B2-C1E2-4F7D-A95A-201EA48C4104Q37974719-0ADED5A3-611D-4EA2-8398-D0AD0D41265BQ38168518-0202A7D7-2B48-4EE0-BC19-232FEE905318Q38212473-3F83CCDB-6334-475A-B5AA-6C8AB6413C88Q38238902-80A50195-000F-4FF8-8FF3-5025B2A71235Q38243361-756C51B0-43E1-42F0-A114-D6C6429B5A51Q38265619-FE4C50DE-0C03-4264-9A52-735145B55204Q38285852-6C78BD79-19A2-48C2-9DD2-26B880CD283BQ38928987-674D287F-638C-44C6-8BFA-CEBB91BA9F4BQ38974236-C4AF07FC-B5C2-481F-9ABA-C3F6CDEA3F98Q39586291-9D9CC848-D780-4763-84EC-6A5043B919C7Q40706746-D37FD9A9-5A04-4F65-BF6F-AE3E8E08F319Q43776863-67E47C49-948E-4C6B-8FC5-ED328C44ED2EQ48798795-EB3F1D80-9885-465F-8C80-D3907DDB79CC
P2860
A non-covalent peptide-based strategy for siRNA delivery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A non-covalent peptide-based strategy for siRNA delivery.
@ast
A non-covalent peptide-based strategy for siRNA delivery.
@en
type
label
A non-covalent peptide-based strategy for siRNA delivery.
@ast
A non-covalent peptide-based strategy for siRNA delivery.
@en
prefLabel
A non-covalent peptide-based strategy for siRNA delivery.
@ast
A non-covalent peptide-based strategy for siRNA delivery.
@en
P2093
P356
P1476
A non-covalent peptide-based strategy for siRNA delivery
@en
P2093
Aldrian-Herrada G
P356
10.1042/BST0350044
P50
P577
2007-02-01T00:00:00Z